CLAZF Earnings
Claritas Pharmaceuticals, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: -99.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Next Earnings
2026-11-30
Estimate vs Actual
Earnings Surprise History
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | annual | 2032-12-31 | $— | $— | — | $— | $3,772,500 |
| 2026-03-31 | annual | 2029-12-31 | $— | $— | — | $3,953,000 | $3,924,646 |
| 2026-03-31 | annual | 2031-12-31 | $— | $— | — | $3,772,500 | $3,688,500 |
| 2026-03-31 | annual | 2030-12-31 | $— | $— | — | $3,688,500 | $3,953,000 |
| 2026-03-31 | annual | 2028-12-31 | $— | $-0.15 | ▼ 0.15 | $3,924,646 | $3,924,646 |
| 2026-03-31 | annual | 2027-12-31 | $-0.15 | $-0.29 | ▼ 0.14 | $— | $— |
| 2026-02-12 | annual | 2031-12-31 | $— | $— | — | $— | $3,772,500 |
| 2026-02-12 | annual | 2030-12-31 | $— | $— | — | $— | $3,688,500 |
| 2026-02-12 | annual | 2027-12-31 | $— | $-0.15 | ▼ 0.15 | $— | $— |
| 2026-02-12 | annual | 2026-12-31 | $— | $-0.29 | ▼ 0.29 | $— | $— |
| 2026-02-12 | annual | 2029-12-31 | $— | $— | — | $— | $3,953,000 |
| 2026-02-12 | annual | 2028-12-31 | $— | $— | — | $— | $3,924,646 |
Earnings Call Transcripts
No transcripts available.